Aller au contenu

Why Cancer Patients Still Die From Infections We Can't Diagnose - Karius

21 juillet 2026 · 51 min

Notes de l’épisode

In this episode of Diagnosing Dx, David Filby is joined by Alec Ford, Chief Executive Officer at Karius.

Alec brings decades of leadership experience across therapeutics, vaccines, and genomics. In this conversation, we explore how Karius is bringing genomics into infectious disease and why the company has focused so sharply on immunocompromised patients.

The scale of the unmet need is staggering. Alec explains that 52% of cancer deaths in the US are due to infection rather than the underlying malignancy, rising to more than 60% in hematologic malignancies. He also shares that there are around 4 million hospital admissions for infection among cancer patients in the US each year, yet the standard hospital workup can still fail to identify the cause in far too many cases.

We also discuss the company’s growth, physician adoption, and why outpatient infectious disease testing could become a major next step.

This is a practical conversation about infectious disease diagnostics, commercialization, and building in one of the most important unmet areas in healthcare.

Key takeaways:

🔹 Why infectious disease remains one of the biggest threats to immunocompromised patients
🔹 How Karius is using microbial cell-free DNA to diagnose infection from a simple blood draw
🔹 Why focus and disciplined market selection have been central to Karius’ growth
🔹 How physician confidence and education shape adoption of new diagnostics
🔹 Why outpatient infectious disease testing could become a major next step for the field

Chapters:
01:00 Introduction and Alec Ford’s background
04:20 Transition from therapeutics to genomics
08:34 The founding story of Karius and how the technology works
14:52 Why Karius focused on immunocompromised patients
19:41 Scaling the company and driving adoption
27:20 Reimbursement, capital strategy, and path to profitability
34:40 The outpatient opportunity and Karius’ next chapter
45:03 Alec’s view on the diagnostics industry and what needs to change

Guest: Alec Ford
Chief Executive Officer at Karius
LinkedIn: https://www.linkedin.com/in/alec-ford-b578003/

Host: David Filby
Founder and CEO of Elevra Consulting
LinkedIn: https://www.linkedin.com/in/davidfilby/

Learn more about Karius here: https://kariusdx.com/

🔔 Subscribe to Diagnosing Dx for weekly conversations with leaders shaping the future of diagnostics and omics.

Tous les épisodes de Diagnosing Dx

Paramètres

Affichage

Langue

Détermine les stations affichées en premier sur la page d’accueil.

Historique

Les stations et épisodes écoutés récemment et tes dernières recherches sont seulement enregistrés dans ce navigateur.

Notifications

Un court message quand un podcast que tu suis publie un nouvel épisode. Désactive un podcast précis avec la cloche sur sa page.

Compte

Enregistrez vos favoris – dans l’app et sur le site.

Raccourcis clavier

/
Ouvrir la recherche
Espace
Lecture ou pause
← →
Dans le lecteur : 15 s en arrière, 30 s en avant (épisodes) · dans une rangée : tuile suivante
↑ ↓
Dans une rangée : cible dans la tuile
Début / Fin
Dans une rangée : première ou dernière tuile
Esc
Fermer la fenêtre ou le menu
?
Cet aperçu
En cours de lecture

Voir la station

À suivre

    Ajoutez des épisodes avec « À suivre » – ils seront lus après l'épisode en cours.